US20150173708A1 - Method and apparatus for placement of implantable device adjacent a body lumen - Google Patents
Method and apparatus for placement of implantable device adjacent a body lumen Download PDFInfo
- Publication number
- US20150173708A1 US20150173708A1 US14/589,361 US201514589361A US2015173708A1 US 20150173708 A1 US20150173708 A1 US 20150173708A1 US 201514589361 A US201514589361 A US 201514589361A US 2015173708 A1 US2015173708 A1 US 2015173708A1
- Authority
- US
- United States
- Prior art keywords
- urethra
- implantable device
- subject matter
- placement
- target site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CC1*C=C(CC2)CC2CCC(C*)CCCCC*C1 Chemical compound CC1*C=C(CC2)CC2CCC(C*)CCCCC*C1 0.000 description 3
- ZTRSRMCMAPHUTL-UHFFFAOYSA-N CCCCCCC(C)C(C)(CCCCC)N=O Chemical compound CCCCCCC(C)C(C)(CCCCC)N=O ZTRSRMCMAPHUTL-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/0841—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
- A61B8/085—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures for locating body or organic structures, e.g. tumours, calculi, blood vessels, nodules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00274—Prostate operation, e.g. prostatectomy, turp, bhp treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3403—Needle locating or guiding means
- A61B2017/3413—Needle locating or guiding means guided by ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
Definitions
- the present subject matter relates to methods and apparatus for implantable devices for treating urinary incontinence.
- Implantation of medical devices into tissue of patients is complicated. Visualization methods are limited by the imaging technologies used and often do not provide an accurate picture of the physiology of the patient and the exact location of the implantable device.
- the present subject matter provides method and apparatus for placement of implantable devices adjacent a body lumen. Some methods include the use of ultrasound for placement of the implantable devices. Some apparatus are provided to improve imaging of the desired target site for positioning of the implantable devices. Such apparatus may be used to deliver echogenic material. Such apparatus may be used to deliver analgesic or other types of material. Such apparatus may be used for hydrodissection.
- FIG. 1 is a sagittal or side view cross section showing male anatomy.
- FIG. 2 is a side view cross section showing male anatomy after a radical prostatectomy.
- FIG. 3 is a top view showing approximate target sites of placement of implantable devices to improve coaptation of a urethra, according to one embodiment of present subject matter.
- FIG. 4 is a view along the length of the urethra in the area of implantation showing approximate target sites of placement of implantable devices to improve coaptation of a urethra, according to one embodiment of present subject matter.
- FIG. 5 is a side view cross section showing approximate placement of implantable devices in patients after radical prostatectomy, according to one embodiment of the present subject matter.
- FIG. 6 is a side view cross section showing approximate placement of implantable devices after Trans-Urethral Resection of the Prostate (TURP), according to one embodiment of the present subject matter.
- FIG. 7 is a side view cross section showing approximate placement of implantable devices including their septa after Trans-Urethral Resection of the Prostate (TURP), according to one embodiment of the present subject matter.
- TURP Trans-Urethral Resection of the Prostate
- FIG. 8 is a side view cross section showing approximate placement of implantable devices including their septa after radical prostatectomy, according to one embodiment of the present subject matter.
- FIG. 9 shows one application of the present subject matter to a patient.
- FIGS. 10-13 show some delivery devices according to various embodiments of the present subject matter.
- FIG. 1 is a sagittal or side view cross section showing male anatomy.
- the bladder 1 is connected to the urethra 2 which exits at the penis 4 .
- a prostate gland 3 surrounds the urethra 2 near the base of the bladder 4 .
- the urethral lumen within the prostate is shown as being constricted either by Benign Prostatic Hyperplasia (BPH) which is treated by TURP or prostate cancer which is treated by radical prostatectomy.
- BPH Benign Prostatic Hyperplasia
- TURP prostate cancer which is treated by radical prostatectomy.
- scrotum 5 and perineum 8 which is the skin behind the scrotum, the anus 6 which is the opening to the rectum 7 , and the pubic bone 9 .
- FIG. 2 is a side view cross section showing male anatomy after a radical prostatectomy.
- the prostate is removed during radical prostatectomy and the cut urethra is brought up and a urethral-vesical anastomosis 17 is provided to the bladder neck with sutures or staples. Removal of the prostate can damage the surrounding or adjacent tissue including the urinary sphincter and/or its enervation, resulting in incontinence due to a loss of coaptation of the urethra.
- tissue bulking devices such as the implantable devices described in U.S. Pat. Nos. 6,045,498, 5,964,806, 6,579,224, and 6,419,624 and their related patents and applications, the descriptions of which are hereby incorporated in their entirety.
- FIG. 3 is a top view of the bladder 1 and urethra 2 showing approximate target sites of placement of implantable devices 10 to improve coaptation of a urethra, according to one embodiment of present subject matter.
- the orientation of the y-axis is along the direction of the urethra 2 in the approximate location of implantation.
- the location is near the bladder neck and urethral vesical anastomosis in the case of radical prostatectomy or further down the urethra at the apex of the prostate after TURP.
- FIG. 4 is a view along the length of the urethra 2 in the area of implantation (or along the y-axis) showing approximate target sites of placement of implantable devices 10 to improve coaptation of a urethra, according to one embodiment of present subject matter.
- One of the difficulties addressed by the teachings provided herein is to assist in the proper location of the implantable devices 10 .
- the accurate placement of the implantable devices 10 along the z-axis (sagittal view) is facilitated by the teachings of the present subject matter.
- FIG. 5 is a side view cross section showing approximate placement of implantable devices 10 in patients after radical prostatectomy, according to one embodiment of the present subject matter. It is understood that implantable devices may be placed in different positions without departing from the scope of the present subject matter. Thus, it is understood that the positions shown in the figures are intended to demonstrate the present subject matter, but are not intended in an exclusive or limited sense.
- biplanar ultrasonic rectal probe can provide planar images of tissue both longitudinally in the XY plane and radially from the rectal ultrasound probe in the rectum parallel to the urethra in the XZ plane. This facilitates placement of the devices at the target site with respect to the position of the urethra and bladder.
- FIG. 6 is a side view cross section showing approximate placement of implantable devices, according to one embodiment of the present subject matter.
- the expandable portion of each implantable device 10 can be placed along the urethra near the apex of the prostate 18 to increase tissue bulking and coaptation in that area.
- An ultrasonic probe 20 can be inserted into the rectum 7 via the anus 6 to assist in imaging the locations of the implantable devices 10 .
- FIG. 6 shows a prostrate gland 3 after TURP and areas 11 indicating resected portion of the prostrate.
- FIG. 9 shows one application of the present subject matter to a patient.
- An ultrasonic rectal probe 20 is used in conjunction with a Foley catheter 21 placed in the urethra with the Foley balloon 22 inflated in the bladder 1 to assist in visualizing the bladder neck and urethra 2 .
- a doctor can rotate the rectal probe 20 to get a picture of the placement of devices with respect to the urethra in an axial segment.
- the doctor can image the bladder neck, proximal urethra and the Foley balloon 22 sitting in the bladder neck.
- the doctor can also get an image of any delivery devices 30 used to deliver fluid to the target location of where the expandable portion of the implant and delivery instruments for the device itself are to be located.
- water can be used.
- Water is echogenic, so it better shows the target location of the expandable portion of the implantable device 10 .
- an analgesic such as lidocaine.
- water with or without an analgesic can be injected at the site intended for the expandable portion of the implantable device 10 to create a pocket in the tissue so that the expandable portion will tend to stay in that position during and after inflation without migrating. This process is called “hydrodissection.”
- the following process is employed to image the target location and accurately place the devices. It is understood that differences in method steps, order of steps, and apparatus can be made without departing from the scope of the present subject matter.
- a doctor may manipulate the delivery device with one hand and the ultrasound with the other to get continuous imaging and feedback.
- the doctor can also continuously switch back and forth between a radial view and a longitudinal view to ensure that the delivery device and/or implantable device is at the right distance along the urethra or from the urethra.
- Various delivery devices 30 in various embodiments can be used to introduce the echogenic fluid and place the expandable portion of the implantable devices.
- FIG. 10 shows one embodiment of a delivery device.
- Syringe 42 is connected to Luer fitting 44 to provide fluid 49 to needle 46 via needle lumen 48 .
- the tip of needle 46 is placed at the desired implantation target site for the expandable portion of the implantable device 10 to inject the fluid 49 .
- FIG. 11 shows one embodiment of a delivery device.
- Device 50 is a pointed trocar 54 with a removable needle portion 52 that is adapted to fit within a channel of the trocar 54 .
- Fluid 59 may be delivered via a channel in the needle portion 52 .
- FIG. 12 shows one embodiment of a delivery device.
- Device 60 is a pointed trocar with fluid channel 64 .
- Device 60 includes a Luer adaptor 62 which can facilitate transfer of fluid via the fluid channel to the implantation target site.
- FIG. 13 shows one embodiment of a delivery device.
- Device 70 includes a sheath 74 that accommodates a pointed trocar 72 and includes a channel 78 with Luer adaptor 76 for delivery of fluid 79 .
- trocar, needle, and sheath combinations may be used without departing from the scope of the present subject matter.
- different fluid channels and Luer connections may be employed to deliver fluid to the intended target site.
- delivery methods using wires placed using sheaths, trocars, and/or other assemblies may be employed to deliver implantable devices to the intended target sites. Some such delivery apparatus and methods are included in the patents and patent applications incorporated by reference herein.
- slotted trocars and/or sheaths may be employed which provide a pathway for implantable devices or needles for delivering fluid to be slid into position in various embodiments.
- implantable devices may include openings or apertures that accommodate a pushrod or other wire to place the implantable devices in tissue at desired target sites. It is further contemplated that one or more implantable devices can be used to enhance coaptation and that the number of devices is not limited to those demonstrated herein. It is understood that delivery devices of various dimensions may be employed to achieve proper placement of the implantable device and septa of such devices.
- the initial approach to the delivery site for the expandable element and hydrodissection at the site is made with a spinal needle.
- the needle is then withdrawn and replaced, again under guidance, with a device for delivering.
- this device includes a pointed trocar within a removable sheath.
- the trocar has a longitudinal channel through which the spinal needle can be passed with a length such that the tip of the needle is located near the tip of the trocar.
- the trocar is hollow along its full length.
- the needle is disposed within the trocar when being inserted into the tissue.
- the needle is then used to deliver echogenic fluid and/or analgesic (if needed).
- the needle is later withdrawn from the trocar assembly to deliver the implantable device.
- the outside diameter of the needle is closely fitted to the inside diameter of the trocar to prevent fluid from leaking back.
- the needle has a locking hub for sealing assembly of the needle and trocar.
- the trocar is delivered without a sheath.
- the trocar is delivered with a sheath.
- the sheath remains while the trocar is removed to provide a tool for delivery of the implantable device.
- a splittable sheath is used. Other embodiments are possible without departing from the scope of the present subject matter.
- a trocar with a fluid port having a Luer lock for attachment of a syringe at or near the handle and a channel along the extent of the trocar (from the port to near the trocar tip) is used.
- a Luer connection on the proximal end is provided to deliver the echogenic fluid and/or analgesic to the distal end.
- the trocar is delivered without a sheath.
- the trocar is delivered with a sheath. In such embodiments, the sheath remains while the trocar is removed to provide a tool for delivery of the implantable device.
- a needle is inserted and followed with a trocar.
- the trocar acts like a dilator.
- the trocar is delivered without a sheath.
- the trocar is delivered with a sheath.
- the sheath remains while the trocar is removed to provide a tool for delivery of the implantable device.
- a sheath with a channel is used to deliver the fluid and/or analgesic.
- a sheath with a piece of thin-walled tubing of small cross sectional area provides the fluid passageway.
- FIG. 7 is a side view cross section showing approximate placement of implantable devices 10 including their septa 14 (in such embodiments), according to one embodiment of the present subject matter.
- the septa 14 can be placed in various tissue locations, such as the scrotum 5 or somewhere in the perineal region 8 .
- Subcutaneous placement of the septa provide for postoperative adjustment of the implantable devices by accessing the septum through the skin with a hypodermic needle.
- Coaptation can be adjusted by any of the procedures provided in the references incorporated by reference herein. For example, a cystoscope can be inserted into the urethra 2 to measure coaptation.
- Other devices, placements, and approaches are possible without departing from the present subject matter.
- FIG. 8 is a side view cross section showing approximate placement of implantable devices 10 including their septa 14 (in such embodiments), according to one embodiment of the present subject matter.
- the septa 14 can be placed in various tissue locations, such as the scrotum 5 or somewhere in the perineal region 8 .
- Subcutaneous placement of the septa provide for postoperative adjustment of the implantable devices.
- Coaptation can be adjusted by any of the procedures provided in the references incorporated by reference herein. For example, a cystoscope can be inserted into the urethra 2 to measure coaptation. Other devices, placements, and approaches are possible without departing from the present subject matter.
- implantable devices may be employed.
- the imaging of such devices may be enhanced by adding echogenic coating or elements within the expandable portion.
- Various imaging methods may include temporarily filling the expandable portion with air to provide enhanced visibility via ultrasound. Other approaches are possible without departing from the scope of the present subject matter.
Abstract
The present subject matter provides method and apparatus for placement of implantable devices adjacent a body lumen. A method of implanting an implantable device at a target site for controllable coaptation of a patient's urethra using an ultrasonic probe inserted into a rectum of the patient comprises inserting a Foley catheter into the urethra, expanding a Foley balloon in the bladder neck, inserting the ultrasonic probe into the rectum of the patient, using the ultrasonic probe to image the urethra and Foley balloon at the bladder neck, placing a small puncture in the perineum, passing a delivery device to the target site under ultra sonic guidance, injecting echogenic fluid at the target site adjacent the urethra, delivering the implantable device to the target site, and adjusting the implantable device to improve coaptation of the urethra.
Description
- This application is a continuation of U.S. patent application Ser. No. 12/411,806, filed Mar. 26, 2009, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/039,738, filed on Mar. 26, 2008, which are hereby incorporated by reference in their entirety.
- The present subject matter relates to methods and apparatus for implantable devices for treating urinary incontinence.
- Implantation of medical devices into tissue of patients is complicated. Visualization methods are limited by the imaging technologies used and often do not provide an accurate picture of the physiology of the patient and the exact location of the implantable device.
- There is a need in the art for improved method and apparatus for implantation of implantable devices.
- The present subject matter provides method and apparatus for placement of implantable devices adjacent a body lumen. Some methods include the use of ultrasound for placement of the implantable devices. Some apparatus are provided to improve imaging of the desired target site for positioning of the implantable devices. Such apparatus may be used to deliver echogenic material. Such apparatus may be used to deliver analgesic or other types of material. Such apparatus may be used for hydrodissection.
- This Summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details about the present subject matter are found in the detailed description and the appended claims. The scope of the present invention is defined by the appended claims and their legal equivalents.
-
FIG. 1 is a sagittal or side view cross section showing male anatomy. -
FIG. 2 is a side view cross section showing male anatomy after a radical prostatectomy. -
FIG. 3 is a top view showing approximate target sites of placement of implantable devices to improve coaptation of a urethra, according to one embodiment of present subject matter. -
FIG. 4 is a view along the length of the urethra in the area of implantation showing approximate target sites of placement of implantable devices to improve coaptation of a urethra, according to one embodiment of present subject matter. -
FIG. 5 is a side view cross section showing approximate placement of implantable devices in patients after radical prostatectomy, according to one embodiment of the present subject matter. -
FIG. 6 is a side view cross section showing approximate placement of implantable devices after Trans-Urethral Resection of the Prostate (TURP), according to one embodiment of the present subject matter. -
FIG. 7 is a side view cross section showing approximate placement of implantable devices including their septa after Trans-Urethral Resection of the Prostate (TURP), according to one embodiment of the present subject matter. -
FIG. 8 is a side view cross section showing approximate placement of implantable devices including their septa after radical prostatectomy, according to one embodiment of the present subject matter. -
FIG. 9 shows one application of the present subject matter to a patient. -
FIGS. 10-13 show some delivery devices according to various embodiments of the present subject matter. - The following detailed description of the present invention refers to subject matter in the accompanying drawings which show, by way of illustration, specific aspects and embodiments in which the present subject matter may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the present subject matter. References to “an”, “one”, or “various” embodiments in this disclosure are not necessarily to the same embodiment, and such references contemplate more than one embodiment. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope is defined only by the appended claims, along with the full scope of legal equivalents to which such claims are entitled.
-
FIG. 1 is a sagittal or side view cross section showing male anatomy. The bladder 1 is connected to theurethra 2 which exits at thepenis 4. Aprostate gland 3 surrounds theurethra 2 near the base of thebladder 4. The urethral lumen within the prostate is shown as being constricted either by Benign Prostatic Hyperplasia (BPH) which is treated by TURP or prostate cancer which is treated by radical prostatectomy. Also shown is thescrotum 5 andperineum 8, which is the skin behind the scrotum, theanus 6 which is the opening to the rectum 7, and thepubic bone 9. -
FIG. 2 is a side view cross section showing male anatomy after a radical prostatectomy. In some embodiments, the prostate is removed during radical prostatectomy and the cut urethra is brought up and a urethral-vesical anastomosis 17 is provided to the bladder neck with sutures or staples. Removal of the prostate can damage the surrounding or adjacent tissue including the urinary sphincter and/or its enervation, resulting in incontinence due to a loss of coaptation of the urethra. One way to increase the coaptation is through the use of tissue bulking devices, such as the implantable devices described in U.S. Pat. Nos. 6,045,498, 5,964,806, 6,579,224, and 6,419,624 and their related patents and applications, the descriptions of which are hereby incorporated in their entirety. -
FIG. 3 is a top view of the bladder 1 andurethra 2 showing approximate target sites of placement ofimplantable devices 10 to improve coaptation of a urethra, according to one embodiment of present subject matter. The orientation of the y-axis is along the direction of theurethra 2 in the approximate location of implantation. The location is near the bladder neck and urethral vesical anastomosis in the case of radical prostatectomy or further down the urethra at the apex of the prostate after TURP. -
FIG. 4 is a view along the length of theurethra 2 in the area of implantation (or along the y-axis) showing approximate target sites of placement ofimplantable devices 10 to improve coaptation of a urethra, according to one embodiment of present subject matter. One of the difficulties addressed by the teachings provided herein is to assist in the proper location of theimplantable devices 10. In particular, the accurate placement of theimplantable devices 10 along the z-axis (sagittal view) is facilitated by the teachings of the present subject matter. -
FIG. 5 is a side view cross section showing approximate placement ofimplantable devices 10 in patients after radical prostatectomy, according to one embodiment of the present subject matter. It is understood that implantable devices may be placed in different positions without departing from the scope of the present subject matter. Thus, it is understood that the positions shown in the figures are intended to demonstrate the present subject matter, but are not intended in an exclusive or limited sense. - One advantage of a biplanar ultrasonic rectal probe is that it can provide planar images of tissue both longitudinally in the XY plane and radially from the rectal ultrasound probe in the rectum parallel to the urethra in the XZ plane. This facilitates placement of the devices at the target site with respect to the position of the urethra and bladder.
-
FIG. 6 is a side view cross section showing approximate placement of implantable devices, according to one embodiment of the present subject matter. For patients with a full orpartial prostate gland 3 after TURP, the expandable portion of eachimplantable device 10 can be placed along the urethra near the apex of theprostate 18 to increase tissue bulking and coaptation in that area. Anultrasonic probe 20 can be inserted into the rectum 7 via theanus 6 to assist in imaging the locations of theimplantable devices 10.FIG. 6 shows aprostrate gland 3 after TURP andareas 11 indicating resected portion of the prostrate. -
FIG. 9 shows one application of the present subject matter to a patient. An ultrasonicrectal probe 20 is used in conjunction with a Foley catheter 21 placed in the urethra with theFoley balloon 22 inflated in the bladder 1 to assist in visualizing the bladder neck andurethra 2. In such applications a doctor can rotate therectal probe 20 to get a picture of the placement of devices with respect to the urethra in an axial segment. By rotating the probe the doctor can image the bladder neck, proximal urethra and theFoley balloon 22 sitting in the bladder neck. The doctor can also get an image of anydelivery devices 30 used to deliver fluid to the target location of where the expandable portion of the implant and delivery instruments for the device itself are to be located. In various applications water can be used. Water is echogenic, so it better shows the target location of the expandable portion of theimplantable device 10. In various uses the water is combined with an analgesic, such as lidocaine. In some embodiments, water with or without an analgesic can be injected at the site intended for the expandable portion of theimplantable device 10 to create a pocket in the tissue so that the expandable portion will tend to stay in that position during and after inflation without migrating. This process is called “hydrodissection.” - In one embodiment, the following process is employed to image the target location and accurately place the devices. It is understood that differences in method steps, order of steps, and apparatus can be made without departing from the scope of the present subject matter.
-
- A Foley catheter is inserted into the urethra and the Foley balloon is inflated with water in the bladder neck.
- An ultrasonic probe is inserted into the rectum of the patient.
- The doctor uses the ultrasonic probe to image the urethra and bladder neck using the echogenetic Foley balloon as a landmark.
- A small puncture in the skin in the perineum is made.
- The doctor chooses a target tissue site near the bladder neck for radical prostatectomy or the apex of the prostate for TURP for placement of analgesic and fluid for hydrodissection of the targeted tissue site.
- The doctor inserts a
delivery device 30 into the small puncture of the perineum and, under ultrasonic visual guidance alternating between radial and longitudinal views as needed, tunnels through the tissue adjacent the urethra. As the delivery device is advanced the doctor may inject analgesic along the path, thus allowing the procedure to be done under local anesthesia. - Once at the intended delivery site more fluid can be injected to create a bolus for hydrodissection of the tissue in preparation for delivery of the expandable device.
- The expandable portion of the implantable device is accurately positioned at the target site.
- The implantable device is then adjusted for proper coaptation.
- For devices with a septum, the septum is placed under the skin. If the procedure is done under local anesthesia the site for the septum is first anesthetized with analgesic via a needle and syringe. Such devices allow for straightforward postoperative adjustment of the urethral coaptation
- The other side of the urethra is then treated using the same or similar procedure.
- It is understood that a doctor may manipulate the delivery device with one hand and the ultrasound with the other to get continuous imaging and feedback. The doctor can also continuously switch back and forth between a radial view and a longitudinal view to ensure that the delivery device and/or implantable device is at the right distance along the urethra or from the urethra.
-
Various delivery devices 30 in various embodiments can be used to introduce the echogenic fluid and place the expandable portion of the implantable devices. -
FIG. 10 shows one embodiment of a delivery device.Syringe 42 is connected to Luer fitting 44 to provide fluid 49 toneedle 46 vianeedle lumen 48. The tip ofneedle 46 is placed at the desired implantation target site for the expandable portion of theimplantable device 10 to inject the fluid 49. -
FIG. 11 shows one embodiment of a delivery device.Device 50 is apointed trocar 54 with aremovable needle portion 52 that is adapted to fit within a channel of thetrocar 54.Fluid 59 may be delivered via a channel in theneedle portion 52. -
FIG. 12 shows one embodiment of a delivery device.Device 60 is a pointed trocar withfluid channel 64.Device 60 includes aLuer adaptor 62 which can facilitate transfer of fluid via the fluid channel to the implantation target site. -
FIG. 13 shows one embodiment of a delivery device.Device 70 includes asheath 74 that accommodates a pointedtrocar 72 and includes achannel 78 withLuer adaptor 76 for delivery offluid 79. - It is understood that a variety of different trocar, needle, and sheath combinations may be used without departing from the scope of the present subject matter. Furthermore, in various embodiments different fluid channels and Luer connections may be employed to deliver fluid to the intended target site. Additionally, delivery methods using wires placed using sheaths, trocars, and/or other assemblies may be employed to deliver implantable devices to the intended target sites. Some such delivery apparatus and methods are included in the patents and patent applications incorporated by reference herein. It is further understood that slotted trocars and/or sheaths may be employed which provide a pathway for implantable devices or needles for delivering fluid to be slid into position in various embodiments. It is also understood that certain embodiments of implantable devices may include openings or apertures that accommodate a pushrod or other wire to place the implantable devices in tissue at desired target sites. It is further contemplated that one or more implantable devices can be used to enhance coaptation and that the number of devices is not limited to those demonstrated herein. It is understood that delivery devices of various dimensions may be employed to achieve proper placement of the implantable device and septa of such devices.
- In one approach the initial approach to the delivery site for the expandable element and hydrodissection at the site is made with a spinal needle. The needle is then withdrawn and replaced, again under guidance, with a device for delivering. In one embodiment, this device includes a pointed trocar within a removable sheath. Other devices and techniques are described in the previously cited patents incorporated by reference in this application. Alternatively or in addition, in some embodiments, the trocar has a longitudinal channel through which the spinal needle can be passed with a length such that the tip of the needle is located near the tip of the trocar. Thus this trocar and needle assembly can be passed through the tissue together and the needle withdrawn after hydrodissection, obviating the need to remove the needle and replace it with a trocar. The trocar is hollow along its full length. The needle is disposed within the trocar when being inserted into the tissue. The needle is then used to deliver echogenic fluid and/or analgesic (if needed). The needle is later withdrawn from the trocar assembly to deliver the implantable device. In various embodiments, the outside diameter of the needle is closely fitted to the inside diameter of the trocar to prevent fluid from leaking back. In various embodiments, the needle has a locking hub for sealing assembly of the needle and trocar. In various embodiments, the trocar is delivered without a sheath. In various embodiments, the trocar is delivered with a sheath. In some embodiments, the sheath remains while the trocar is removed to provide a tool for delivery of the implantable device. In some embodiments a splittable sheath is used. Other embodiments are possible without departing from the scope of the present subject matter.
- In one approach, a trocar with a fluid port having a Luer lock for attachment of a syringe at or near the handle and a channel along the extent of the trocar (from the port to near the trocar tip) is used. Thus obviating the need for a separate needle. In various embodiments, a Luer connection on the proximal end is provided to deliver the echogenic fluid and/or analgesic to the distal end. In various embodiments, the trocar is delivered without a sheath. In various embodiments, the trocar is delivered with a sheath. In such embodiments, the sheath remains while the trocar is removed to provide a tool for delivery of the implantable device.
- In one approach, a needle is inserted and followed with a trocar. In such embodiments, the trocar acts like a dilator. In various embodiments, the trocar is delivered without a sheath. In various embodiments, the trocar is delivered with a sheath. In such embodiments, the sheath remains while the trocar is removed to provide a tool for delivery of the implantable device.
- In one approach, a sheath with a channel is used to deliver the fluid and/or analgesic. In various embodiments, a sheath with a piece of thin-walled tubing of small cross sectional area provides the fluid passageway.
- Better placement of the expandable portion of the implantable device provides better coaptation of the urethra with less volume. Consequently, less acute pressures on the expandable portion of the implantable device are needed. It is believed that lower volumes result in fewer device failures, fewer tissue erosion issues and less chance for device migration.
-
FIG. 7 is a side view cross section showing approximate placement ofimplantable devices 10 including their septa 14 (in such embodiments), according to one embodiment of the present subject matter. It is understood that thesepta 14 can be placed in various tissue locations, such as thescrotum 5 or somewhere in theperineal region 8. Subcutaneous placement of the septa provide for postoperative adjustment of the implantable devices by accessing the septum through the skin with a hypodermic needle. Coaptation can be adjusted by any of the procedures provided in the references incorporated by reference herein. For example, a cystoscope can be inserted into theurethra 2 to measure coaptation. Other devices, placements, and approaches are possible without departing from the present subject matter. -
FIG. 8 is a side view cross section showing approximate placement ofimplantable devices 10 including their septa 14 (in such embodiments), according to one embodiment of the present subject matter. It is understood that thesepta 14 can be placed in various tissue locations, such as thescrotum 5 or somewhere in theperineal region 8. Subcutaneous placement of the septa provide for postoperative adjustment of the implantable devices. Coaptation can be adjusted by any of the procedures provided in the references incorporated by reference herein. For example, a cystoscope can be inserted into theurethra 2 to measure coaptation. Other devices, placements, and approaches are possible without departing from the present subject matter. - While the method and apparatus provided herein are demonstrated for application to the male, it is understood that they are applicable to female applications as well. Likewise they are applicable in general to provide coaptation to other lumens within the body such as the anal canal and rectum or the esophagus.
- It is understood that various implantable devices may be employed. The imaging of such devices may be enhanced by adding echogenic coating or elements within the expandable portion. Various imaging methods may include temporarily filling the expandable portion with air to provide enhanced visibility via ultrasound. Other approaches are possible without departing from the scope of the present subject matter.
- This application is intended to cover adaptations and variations of the present subject matter. It is to be understood that the above description is intended to be illustrative, and not restrictive. The scope of the present subject matter should be determined with reference to the appended claim, along with the full scope of legal equivalents to which the claims are entitled.
Claims (1)
1. A method of implanting an implantable device at a target site for controllable coaptation of a patient's urethra using an ultrasonic probe inserted into a rectum of the patient, comprising:
inserting a Foley catheter into the urethra;
expanding a Foley balloon in the bladder neck;
inserting the ultrasonic probe into the rectum of the patient;
using the ultrasonic probe to image the urethra and Foley balloon at the bladder neck;
placing a small puncture in the perineum;
passing a delivery device to the target site under ultrasonic guidance;
delivering the implantable device to the target site; and
adjusting the implantable device to improve coaptation of the urethra.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/589,361 US20150173708A1 (en) | 2008-03-26 | 2015-01-05 | Method and apparatus for placement of implantable device adjacent a body lumen |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3973808P | 2008-03-26 | 2008-03-26 | |
US12/411,806 US8926494B1 (en) | 2008-03-26 | 2009-03-26 | Method and apparatus for placement of implantable device adjacent a body lumen |
US14/589,361 US20150173708A1 (en) | 2008-03-26 | 2015-01-05 | Method and apparatus for placement of implantable device adjacent a body lumen |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/411,806 Continuation US8926494B1 (en) | 2008-03-26 | 2009-03-26 | Method and apparatus for placement of implantable device adjacent a body lumen |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150173708A1 true US20150173708A1 (en) | 2015-06-25 |
Family
ID=52117215
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/411,806 Active 2030-07-09 US8926494B1 (en) | 2008-03-26 | 2009-03-26 | Method and apparatus for placement of implantable device adjacent a body lumen |
US14/589,361 Abandoned US20150173708A1 (en) | 2008-03-26 | 2015-01-05 | Method and apparatus for placement of implantable device adjacent a body lumen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/411,806 Active 2030-07-09 US8926494B1 (en) | 2008-03-26 | 2009-03-26 | Method and apparatus for placement of implantable device adjacent a body lumen |
Country Status (1)
Country | Link |
---|---|
US (2) | US8926494B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9861384B1 (en) * | 2013-10-18 | 2018-01-09 | Uromedica, Inc. | Trocar and sheath assembly for placement of implantable device adjacent a body lumen |
WO2020155857A1 (en) * | 2019-01-29 | 2020-08-06 | 上海氪励铵勤科技发展有限公司 | Intraoperative implant for male posterior urethra resection and reconstruction surgery and method for implanting same |
US11510766B2 (en) | 2019-02-14 | 2022-11-29 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
BR122019017170B1 (en) | 2015-08-18 | 2022-08-16 | B. Braun Melsungen Ag | CATHETER ASSEMBLY |
US11185250B2 (en) | 2016-02-05 | 2021-11-30 | Boston Scientific Scimed, Inc. | Medical devices and related methods of use |
JP7150871B2 (en) | 2017-12-23 | 2022-10-11 | テレフレックス ライフ サイエンシズ リミテッド | Expandable tissue engagement device and method |
US11850377B2 (en) | 2018-12-17 | 2023-12-26 | B. Braun Melsungen Ag | Catheter assemblies and related methods |
AU2020358845A1 (en) | 2019-10-04 | 2022-03-03 | Innovacell Ag | Parallel path puncture device guide |
MX2022016398A (en) * | 2020-06-16 | 2023-01-30 | Innovacell Ag | Parallel path puncture device guide and method. |
US11759301B2 (en) | 2020-06-23 | 2023-09-19 | Uromedica, Inc. | Method and apparatus for fixation of implantable device for urinary continence |
US20230080136A1 (en) | 2021-09-14 | 2023-03-16 | Uromedica, Inc. | Implantable urinary continence device with helical anchor |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070276342A1 (en) * | 2006-03-28 | 2007-11-29 | Bryant Lin | Devices and related methods for treating incontinence |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4832680A (en) * | 1986-07-03 | 1989-05-23 | C.R. Bard, Inc. | Apparatus for hypodermically implanting a genitourinary prosthesis |
US5320617A (en) * | 1993-06-25 | 1994-06-14 | Leach Gary E | Method of laser-assisted prostatectomy and apparatus for carrying out the method |
DE69821127T2 (en) * | 1997-02-13 | 2004-06-09 | Boston Scientific Ltd., St. Michael | PERCUTANEOUS AND HIATAL DEVICES FOR USE IN MINIMALLY INVASIVE PELVIC SURGERY |
US6045498A (en) | 1997-06-12 | 2000-04-04 | Uromedica, Inc. | Method for adjustably restricting a body lumen |
US6579224B1 (en) | 1999-10-11 | 2003-06-17 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
US6419624B1 (en) | 1999-10-11 | 2002-07-16 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
US20020010502A1 (en) * | 1998-04-01 | 2002-01-24 | Trachtenberg John R. | Thermotherapy method |
JP5090600B2 (en) * | 2000-02-18 | 2012-12-05 | トーマス ジェイ. フォガーティー, | Improved device for accurately marking tissues |
EP1434530A2 (en) * | 2001-10-12 | 2004-07-07 | AMS Research Corporation | Surgical instrument and method |
WO2004000103A2 (en) * | 2002-06-24 | 2003-12-31 | Noyes William R | Fillers and methods for displacing tissues to improve radiological outcomes |
CA2433205A1 (en) * | 2003-03-18 | 2004-09-18 | James Alexander Keenan | Drug delivery, bodily fluid drainage, and biopsy device with enhanced ultrasonic visibility |
US7914437B2 (en) * | 2005-02-04 | 2011-03-29 | Ams Research Corporation | Transobturator methods for installing sling to treat incontinence, and related devices |
US7837670B2 (en) * | 2005-03-22 | 2010-11-23 | Boston Scientific Scimed, Inc. | Methods and devices for delivering therapeutic agents into the prostate gland |
US7647113B2 (en) * | 2006-12-21 | 2010-01-12 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
-
2009
- 2009-03-26 US US12/411,806 patent/US8926494B1/en active Active
-
2015
- 2015-01-05 US US14/589,361 patent/US20150173708A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070276342A1 (en) * | 2006-03-28 | 2007-11-29 | Bryant Lin | Devices and related methods for treating incontinence |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9861384B1 (en) * | 2013-10-18 | 2018-01-09 | Uromedica, Inc. | Trocar and sheath assembly for placement of implantable device adjacent a body lumen |
US9962185B2 (en) | 2013-10-18 | 2018-05-08 | Uromedica, Inc. | Trocar and sheath assembly for placement of implantable device adjacent a body lumen |
WO2020155857A1 (en) * | 2019-01-29 | 2020-08-06 | 上海氪励铵勤科技发展有限公司 | Intraoperative implant for male posterior urethra resection and reconstruction surgery and method for implanting same |
US11510766B2 (en) | 2019-02-14 | 2022-11-29 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
US11690703B2 (en) | 2019-02-14 | 2023-07-04 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
US11690704B2 (en) | 2019-02-14 | 2023-07-04 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
Also Published As
Publication number | Publication date |
---|---|
US8926494B1 (en) | 2015-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8926494B1 (en) | Method and apparatus for placement of implantable device adjacent a body lumen | |
CN102905633B (en) | Multi-fluid cutting tissue method and apparatus | |
US7077842B1 (en) | Over-the-wire high frequency electrode | |
US8617196B2 (en) | Method and apparatus for performing needle guided interventions | |
EP3160566B1 (en) | Tissue sampling and cancer treatment apparatus | |
US10016621B2 (en) | Prostate treatment apparatus | |
US20040002647A1 (en) | Gel injection treatment of body parts | |
JP2017038954A (en) | Prostate treatment system and method | |
US20080114286A1 (en) | Infusion Catheter | |
WO1993004727A1 (en) | Balloon-catheter | |
CZ313798A3 (en) | Lase application set | |
US11918414B2 (en) | Controlled tissue dissection systems and methods | |
US20080033570A1 (en) | Prostatic stent placement device | |
US6422997B1 (en) | Prostate visualization device and methods of use | |
EP1165178A1 (en) | Implant positioning system and method | |
US20030171646A1 (en) | Implant positioning system and method | |
US9962185B2 (en) | Trocar and sheath assembly for placement of implantable device adjacent a body lumen | |
US20050124852A1 (en) | Method and device for the treatment of incontinence | |
US20080171905A1 (en) | Transvaginal Delivery of Bulking Masses Adjacent the Urethra to Alleviate Female Incontinence | |
McNicholas et al. | Suprapubic endoscopy: a percutaneous approach | |
US20230073955A1 (en) | Kit and method intended for prostate surgery | |
US11938289B2 (en) | Kit and method intended for prostate surgery | |
US20240091504A1 (en) | Kit and method intended for prostate surgery | |
US11864986B2 (en) | Method and apparatus for fixation of implantable device for urinary continence | |
US20230338705A1 (en) | Kit and method intended for prostate surgery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UROMEDICA, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:COOK, TIMOTHY C.;BURTON, JOHN H.;REEL/FRAME:035165/0563 Effective date: 20090526 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |